Alzamend Neuro, Inc.ALZNNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank78
Year-over-Year Change

Price-to-earnings ratio

Latest
-0.52
↑ 100% vs avg
Percentile
P78
Within normal range
Streak
1 yr
Consecutive declineElevated
Average
-146.83
Historical baseline
PeriodValueYoY Change
2025-0.52-8.5%
2024-0.48+86.1%
2023-3.47+52.1%
2022-7.24+96.2%
2021-191.39+10.9%
2020-214.90-33.3%
2019-161.18+75.0%
2018-645.31-164.7%
2017-243.77-
20160.00-